Exciting Swiss Start-Ups featured in Labiotech
Basel, Lausanne, Geneva & Zurich are all buzzing
Digital Biomarker specialist Monument Tx launches
Early Alzheimer’s test pioneers Pre-Diagnostics profiled in Medtech-Insight
Elicera lists on the Nasdaq First North Growth Market!
Early Alzheimer’s test pioneers Pre-Diagnostics profiled in Medtech-Insight
Life Signals receives CE mark for remote vital signs monitoring plaform
Early Alzheimer’s test pioneers Pre-Diagnostics profiled in Medtech-Insight
Leading neurosurgeons join Hemispherian’s SAB
Early Alzheimer’s test pioneers Pre-Diagnostics profiled in Medtech-Insight
Early Alzheimer’s test pioneers Pre-Diagnostics profiled in Medtech-Insight
Early Alzheimer’s test pioneers Pre-Diagnostics profiled in Medtech-Insight
360DX profiles Immunovia in CLIA lead-up
LUND, April 29: In-depth profile of longstanding MDx client Immunovia by Leo O’Connor as CLIA approval nears for its PanCan-D blood biomarker test for aiding early pancreatic cancer diagnosis. www.360dx.com
Swissfillon generates a buzz
VISP, APRIL 22, 2021: Swissfillon are carving a great niche for fill&finish of advanced therapeutics and we have been creating awareness in key journals such as OnDrugDelivery.www.swissfillon.com .
Sinai joins RhoVac’s multicenter trial
LUND, APRIL 21, 2021:Mount Sinai has joined RhoVac’s multicenter trial of RV1001 in post-surgical and -radiotherapy patients with prostate cancer. RV1001 blocks the RhoC protein which appears to be involved in metastasis. www.rhovac.com .
2021 Swiss Biotech Report Published
ZURICH, APRIL 20th 2021: We worked with the Swiss Biotech Association to produce this year’s Swiss Biotech Report with the them leadership, agility and innovation in the time of COVID-19. Copies can be downloaded at www.swissbiotech.org